OpenAlex
PricingAboutJobs
Log inGet started
Work

The proteasome inhibitor bortezomib sensitizes cells to killing by death receptor ligand TRAIL via BH3-only proteins Bik and Bim

HTML

Year: 2005
Type: article
Source: Molecular Cancer Therapeutics
DOI: 10.1158/1535-7163.mct-04-0260
Authors: Malti Nikrad, Thomas Johnson, Hamsa Puthalalath, Leigh Coultas, Jerry Adams, Andrew S. Kraft
Institutions: Medical University of South Carolina, MUSC Hollings Cancer Center, University of Colorado Denver, Walter and Eliza Hall Institute of Medical Research
Language: English

Topic: Cell death mechanisms and regulation
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: bortezomib, TRAIL, BH3-only proteins, BIK, building information modeling, Bcl-2 family proteins, apoptosis, proteasome inhibition, death receptor signaling, mitochondrial apoptosis, Apaf-1, prostate cancer, colon cancer, drug synergy
SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute
Award: G330228232
OpenAlex ID: W1911504906
FWCI: 7.745
Cites: 39
Cited by: 197
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms